Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

No phase data

Trial Status

Recruiting1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT05356520Not ApplicableRecruiting
Comparison of Different Operations for Siewert Type II Adenocarcinoma of Esophagogastric Junction
Siewert Type II Adenocarcinoma of Esophagogastric Junction
PrincipalinvestigatorStart date: 2022-05-01

Research Network

Collaboration Network

6 collaborators·15 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

The First Affiliated Hospital of Shanxi Medical University

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Sandro Mattioli - Alma M Studiorum-University, MD

Department of Medical and Surgical Sciences

Moderately Similar
1 trials

Shared therapeutic areas:

Siewert Type II Adenocarcinoma of Esophagogastric Junction
Similarity Score30%

Andrey Ryabov, MD, PhD

P.Herzen Moscow Oncological Research Institute

Moderately Similar
5 trials

Shared therapeutic areas:

Siewert Type II Adenocarcinoma of Esophagogastric Junction
Similarity Score30%

Jian-Kun Hu, M.D. Ph.D.

West China Hospital

Moderately Similar
4 trials

Shared therapeutic areas:

Siewert Type II Adenocarcinoma of Esophagogastric Junction

Worked with same sponsors:

Tang-Du Hospital
Similarity Score30%

wei wang, M.D.,Ph.D

Guangdong PHTCM

Moderately Similar
1 trials

Shared therapeutic areas:

Siewert Type II Adenocarcinoma of Esophagogastric Junction
Similarity Score30%

Nuriddin Abdulkhakimov, PhD

P.Herzen Moscow Oncological Research Institute

Moderately Similar
1 trials

Shared therapeutic areas:

Siewert Type II Adenocarcinoma of Esophagogastric Junction
Similarity Score30%

Melissa Lumish, MD

University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center

Moderately Similar
1 trials

Shared therapeutic areas:

Siewert Type II Adenocarcinoma of Esophagogastric Junction
Similarity Score30%

Pavel Smirnov

P.Herzen Moscow Oncological Research Institute

Moderately Similar
3 trials

Shared therapeutic areas:

Siewert Type II Adenocarcinoma of Esophagogastric Junction
Similarity Score30%

Vladimir Khomyakov, MD, PhD

P.Herzen Moscow Oncological Research Institute

Moderately Similar
4 trials

Shared therapeutic areas:

Siewert Type II Adenocarcinoma of Esophagogastric Junction
Similarity Score30%

peichun sun, MD,PH.D

Henan Provincial People's Hospital

Related
1 trials

Shared therapeutic areas:

Siewert Type II Adenocarcinoma of Esophagogastric Junction

Worked with same sponsors:

First Affiliated Hospital Xi'an Jiaotong UniversityGeneral Hospital of Ningxia Medical University+4 more
Collaborated on 1 trial
Similarity Score14%

lei wang, MD,PH.D

General Hospital of Ningxia Medical University

Related
1 trials

Shared therapeutic areas:

Siewert Type II Adenocarcinoma of Esophagogastric Junction

Worked with same sponsors:

First Affiliated Hospital Xi'an Jiaotong UniversityGeneral Hospital of Ningxia Medical University+4 more
Collaborated on 1 trial
Similarity Score14%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT05356520Not ApplicablePrincipalInvestigator

Comparison of Different Operations for Siewert Type II Adenocarcinoma of Esophagogastric Junction

Siewert Type II Adenocarcinoma of Esophagogastric Junction
Recruiting

All 1 trials loaded